DoctorAdam Review
Best for: adults seeking compounded oral or injectable GLP-1s with flat all-in monthly pricing
DoctorAdam is a Shopify-based telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral tablet forms, with flat all-in monthly pricing covering physician evaluation, medication, and free shipping. Pharmacy partners include Olympia Pharmaceuticals (Orlando, FL) and Carie Boyd Pharmaceuticals (Irving, TX). LegitScript certified with a 4.8/5 Trustpilot score from over 5,400 reviews and 100K+ patients served across 44 states.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
DoctorAdam is a solid telehealth option with balanced features and pricing.
DoctorAdam at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $129/mo (Injection form. Verbatim from /pages/semaglutide: 'From $129'. Page compares to Ozempic® & Wegovy®, confirming compounded. 'Includes physician evaluation, prescription, medication, and shipping.')
- What's included
- Medication · Consult · Shipping
- Availability
- 44 states
- FDA status
- No FDA warning letter on record
How we scored DoctorAdam
Each dimension is scored algorithmically from DoctorAdam’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.9/10At $129/mo, DoctorAdam runs about 24% below the $170 median for GLP-1 providers.
Effectiveness25%
8.0/10DoctorAdam offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.1/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-03).
Accessibility10%
7.8/10DoctorAdam is available in 44 states.
Support10%
5.7/10DoctorAdam provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this DoctorAdam review
Last checked 2026-07-03- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in 44 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications DoctorAdam offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Injection form. Verbatim from /pages/semaglutide: 'From $129'. Page compares to Ozempic® & Wegovy®, confirming compounded. 'Includes physician evaluation, prescription, medication, and shipping.'
Injection form. Verbatim from /pages/tirzepatide-injection: 'From $229 | Get Treatment'. 'Your price includes physician evaluation, prescription, medication, and shipping.'
Oral tablet form. Verbatim from /pages/oral-semaglutide: 'From $129'. Doses 2mg–24mg; physician determines strength. 'Includes medication & prescription.'
Oral tablet form. Verbatim from /pages/tirzepatide-oral-tablet: 'From $199 | Get Treatment'. Doses 3–5–6–10–20 mg; '30 oral tablets for once-daily dosing as prescribed.'
Ready to get started?
Plans and promotions change often — check DoctorAdam's current pricing and active discounts before you decide.
What we like
- Offers both injection and oral tablet forms of compounded semaglutide and tirzepatide
- Flat all-in pricing — physician evaluation, medication, and free shipping included
- Named pharmacy partners: Olympia Pharmaceuticals (Orlando, FL) and Carie Boyd Pharmaceuticals (Irving, TX)
- LegitScript certified with 4.8/5 Trustpilot score from 5,400+ reviews and 100K+ patients
- No hidden fees, no required recurring commitment, full refund if not prescribed
Watch-outs
- Compounded medications are not FDA-approved individual drugs
- No labs or dedicated coaching disclosed on public pages
- Only 44 states served — AK, MA, MS, NJ, RI, and VT excluded despite homepage '50 states' claim
- Dose-tier pricing not published; only starting prices visible without quiz
- Shopify-based store rather than a dedicated health platform
Is DoctorAdam worth it? Our verdict
DoctorAdam positions itself around one thing: adults seeking compounded oral or injectable GLP-1s with flat all-in monthly pricing. It runs $129/month — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
How much DoctorAdam actually costs
- Compounded semaglutide — $129/month
- Compounded tirzepatide — $229/month
- Compounded semaglutide — $129/month
- Compounded tirzepatide — $199/month
That puts DoctorAdam below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Medications: what DoctorAdam prescribes
DoctorAdam prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
DoctorAdam's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who DoctorAdam is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
DoctorAdam is available in 44 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
DoctorAdam earns its place on the shortlist mainly on price: at $129/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
Ready to start with DoctorAdam?
Starting at $129/month. See current pricing and start your free consultation.
Alternatives to DoctorAdam
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this DoctorAdam review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with DoctorAdam?
Starting at $129/month. See current pricing and start your free consultation.